"T-Lymphocytes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.
| Descriptor ID |
D013601
|
| MeSH Number(s) |
A11.118.637.555.567.569 A15.145.229.637.555.567.569 A15.382.490.555.567.569
|
| Concept/Terms |
T-Lymphocytes- T-Lymphocytes
- T Lymphocytes
- T-Lymphocyte
- T-Cells
- T Cells
- T-Cell
- Thymus-Dependent Lymphocytes
- Lymphocyte, Thymus-Dependent
- Lymphocytes, Thymus-Dependent
- Thymus Dependent Lymphocytes
- Thymus-Dependent Lymphocyte
|
Below are MeSH descriptors whose meaning is more general than "T-Lymphocytes".
Below are MeSH descriptors whose meaning is more specific than "T-Lymphocytes".
This graph shows the total number of publications written about "T-Lymphocytes" by people in this website by year, and whether "T-Lymphocytes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 8 | 2 | 10 |
| 1997 | 6 | 3 | 9 |
| 1998 | 12 | 4 | 16 |
| 1999 | 3 | 6 | 9 |
| 2000 | 7 | 5 | 12 |
| 2001 | 7 | 6 | 13 |
| 2002 | 11 | 17 | 28 |
| 2003 | 12 | 17 | 29 |
| 2004 | 12 | 12 | 24 |
| 2005 | 15 | 13 | 28 |
| 2006 | 17 | 15 | 32 |
| 2007 | 18 | 20 | 38 |
| 2008 | 19 | 15 | 34 |
| 2009 | 20 | 9 | 29 |
| 2010 | 18 | 14 | 32 |
| 2011 | 17 | 15 | 32 |
| 2012 | 14 | 13 | 27 |
| 2013 | 20 | 12 | 32 |
| 2014 | 19 | 5 | 24 |
| 2015 | 25 | 10 | 35 |
| 2016 | 19 | 14 | 33 |
| 2017 | 30 | 17 | 47 |
| 2018 | 32 | 13 | 45 |
| 2019 | 24 | 7 | 31 |
| 2020 | 27 | 19 | 46 |
| 2021 | 23 | 25 | 48 |
| 2022 | 4 | 32 | 36 |
| 2023 | 8 | 38 | 46 |
| 2024 | 16 | 25 | 41 |
| 2025 | 18 | 9 | 27 |
| 2026 | 13 | 8 | 21 |
To return to the timeline,
click here.
Below are the most recent publications written about "T-Lymphocytes" by people in Profiles.
-
Promises and potential pitfalls of in vivo CAR gene therapy. Blood. 2026 Jul 30; 148(5):535-544.
-
Durable stable disease and immune activation in metastatic uveal melanoma treated with tebentafusp: case report. Front Immunol. 2026; 17:1864115.
-
Biomarker study of pembrolizumab in patients with advanced rare cancers. Cell Rep Med. 2026 Jun 16; 7(6):102827.
-
Identification of a persistent Ascaris-derived Kalirin epitope associated with chronic T cell activation in the lung. PLoS Negl Trop Dis. 2026 Jun; 20(6):e0014434.
-
Cell-type- and state-resolved transcriptomics uncovers distinct T cell and monocyte dysregulation in multiple sclerosis. Cell Rep. 2026 Jun 23; 45(6):117417.
-
Coexpression of IL15 Promotes Effector Differentiation and Sustained Proliferative Capacity in ALPPL2-Specific Human CAR T Cells. Cancer Immunol Res. 2026 Jun 02; 14(6):933-943.
-
CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multisite, retrospective cohort review. Blood Adv. 2026 May 26; 10(10):3467-3479.
-
Variability in the TLR3 type I interferon pathway is predictive of RNA vaccine responses. Sci Adv. 2026 May 15; 12(20):eaed8930.
-
Evolution of tumor subclones and T-cell dynamics underlie variable ibrutinib responses in Waldenstr?m macroglobulinemia. Blood. 2026 May 14; 147(20):2298-2314.
-
Unbiased niche labeling maps immune-excluded niche in bone metastasis. Cell. 2026 May 28; 189(11):3287-3305.e25.